FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Akums Drugs and Pharmaceuticals IPO and Emcure Pharma IPO.
Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Akums Drugs and Pharmaceuticals IPO | Emcure Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited |
Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.
Akums Drugs and Pharmaceuticals IPO | Emcure Pharma IPO | |
---|---|---|
Face Value | ₹2 per share | ₹10 per share |
Issue Price (Lower) | ₹646.00 per share | ₹960.00 per share |
Issue Price (Upper) | ₹679.00 per share | ₹1,008.00 per share |
Issue Price (Final) | ₹679.00 per share | ₹1,008.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹64.00 per share | ₹90.00 per share |
Market Lot Size | 22 shares | 14 shares |
Fresh Issue Size | 1,00,14,727 shares | 79,36,507 shares |
Fresh Issue Size (Amount) | up to ₹680.00 Cr | up to ₹800.00 Cr |
OFS Issue Size | 1,73,30,435 shares | 1,14,28,839 shares |
OFS Issue Size (Amount) | up to ₹1,176.74 Cr | up to ₹1,152.03 Cr |
Issue Size Total | 2,73,45,162 shares | 1,93,65,346 shares |
Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹1,952.03 Cr |
Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Emcure Pharma IPO is Aug 01, 2024, and Jul 05, 2024, respectively.
Akums Drugs and Pharmaceuticals IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Bid Date | Jul 29, 2024 | Jul 02, 2024 |
Issue Open | Jul 30, 2024 | Jul 03, 2024 |
Issue Close | Aug 01, 2024 | Jul 05, 2024 |
Basis Of Allotment (Tentative) | Aug 02, 2024 | Jul 08, 2024 |
Initiation of Refunds (Tentative) | Aug 05, 2024 | Jul 09, 2024 |
Credit of Share (Tentative) | Aug 05, 2024 | Jul 09, 2024 |
Listing date (Tentative) | Aug 06, 2024 | Jul 10, 2024 |
Anchor Lockin End date 1 | Sep 01, 2024 | Aug 07, 2024 |
Anchor Lockin End date 2 | Oct 31, 2024 | Oct 06, 2024 |
Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Emcure Pharma IPO P/E ratio of 34.55.
Akums Drugs and Pharmaceuticals IPO | Emcure Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 84.94% | 98.90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 78.24% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 34.55 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹19029.89 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 0.11%% | 16.90%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 3.37%% | 19.37%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.69 | 0.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹29.17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | -0.57% | 16.87%% |
In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Emcure Pharma IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and 38,53,234 shares in Emcure Pharma IPO.
Akums Drugs and Pharmaceuticals IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | 1,22,05,912 shares | 57,79,850 shares |
Market Maker Reserveration | ||
QIB | 81,37,276 shares | 38,53,234 shares |
NII | 40,68,637 shares | 28,89,926 shares |
RII | 27,12,424 shares | 67,43,160 shares |
Employee | 2,43,902 shares | 1,08,900 shares |
Others | ||
Total | 1,51,62,239 shares | 1,37,03,538 shares |
Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Emcure Pharma IPO subscribed 67.87x.
Akums Drugs and Pharmaceuticals IPO | Emcure Pharma IPO | |
---|---|---|
QIB (times) | 90.09x | 191.24x |
NII (times) | 42.10x | 49.32x |
Big NII (times) | 47.43x | 54.90x |
Small NII (times) | 31.45x | 38.16x |
RII (times) | 20.80x | 7.36x |
Employee (times) | 4.14x | 8.81x |
Other (times) | ||
Total (times) | 63.44x | 67.87x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|